Are you looking to make some news additions to your portfolio in March?
If you are, then read on because listed below are two ASX 200 growth shares that have been given buy ratings by brokers.
Here's what you need to know about them:
Breville Group Ltd (ASX: BRG)
The first ASX 200 growth share that is highly rated by brokers is Breville.
It is the leading appliance manufacturer behind popular brands such as Breville, Sage, Kambrook, and Baratza.
These appliances are found in countless kitchens across Australia and, thanks to the company's ongoing and highly successful international expansion, kitchens across the world.
This underpinned a strong performance during the first half of FY 2025. Breville reported a 10.1% increase in revenue to $997.5 million and a 16.1% lift in net profit after tax to $97.5 million.
The team at Macquarie is very positive on the company. The broker is positive on Breville's outlook thanks to new product launches and its expansion into the China market.
It currently has an outperform rating and $41.10 price target on Breville's shares. Based on its current share price of $33.67, this suggests that upside of 22% is possible for investors between now and this time next year.
Life360 Inc (ASX: 360)
Another ASX 200 growth share that has been tipped as a buy is Life360.
It is a technology company operating in the digital consumer subscription services market.
Life360's focus is on products and services for digitally native families. Its key product is the incredibly popular Life360 app, which has almost 80 million monthly active users, and offers families features such as communications, driver safety, and location sharing.
Thanks to the rapid growth of its user base and particularly its paid subscribers, the company has been growing its revenue and operating earnings at a quick rate.
This led to the company reporting annualised monthly revenue (AMR) growth of 34% to US$367.6 million and the doubling of adjusted EBITDA to US$45.5 million in FY 2024.
The good news is that this positive form is expected to continue in FY 2025, with the company recently guiding to revenue growth of 21% to 29% and adjusted EBITDA growth of 43% to 65%.
This has impressed the team at Goldman Sachs. So much so, the broker responded to Life360's results release last month by retaining its buy rating and lifting its price target to $27.00.
Based on its current share price of $22.40, this implies potential upside of just over 20% for investors over the next 12 months.
